Brief: Tarsus Announces Transition Plans For Board Of Directors
11/10/2022 13:38
Oct 11 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O :
* TARSUS ANNOUNCES TRANSITION PLANS FOR BOARD OF DIRECTORS
* TARSUS PHARMACEUTICALS INC- CO-FOUNDER AND CHAIRMAN
MICHAEL
ACKERMANN PLANS TO TRANSITION OFF BOARD OF DIRECTORS
* TARSUS PHARMACEUTICALS INC- CEO BOBAK AZAMIAN WILL BECOME
CHAIRMAN UPON DR. ACKERMANN'S EXPECTED TRANSITION
* TARSUS PHARMACEUTICALS INC- WENDY YARNO WILL BECOME LEAD
INDEPENDENT DIRECTOR
Source text for Eikon: ID:nGNX2SGn0f
Further company coverage: TARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)